BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35069439)

  • 1. Interplay Between Thyroid Hormone Status and Pulmonary Hypertension in Graves' Disease: Relevance of the Assessment in Thyrotoxic and Euthyroid Patients.
    Araruna LVM; de Oliveira DC; Pereira MC; Moura Neto A; Tambascia MA; Zantut-Wittmann DE
    Front Endocrinol (Lausanne); 2021; 12():780397. PubMed ID: 35069439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperdynamic Right Heart Function in Graves' Hyperthyroidism Measured by Echocardiography Normalises on Restoration of Euthyroidism.
    Teasdale SL; Inder WJ; Stowasser M; Stanton T
    Heart Lung Circ; 2017 Jun; 26(6):580-585. PubMed ID: 28025026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
    Yoshimura Noh J; Momotani N; Fukada S; Ito K; Miyauchi A; Amino N
    Endocr J; 2005 Oct; 52(5):537-42. PubMed ID: 16284430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right ventricular and pulmonary function in sickle cell disease patients with pulmonary hypertension.
    Akgül F; Yalçin F; Babayiğit C; Seyfeli E; Seydaliyeva T; Gali E
    Pediatr Cardiol; 2006; 27(4):440-6. PubMed ID: 16835804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study.
    Pearce SHS; Dayan C; Wraith DC; Barrell K; Olive N; Jansson L; Walker-Smith T; Carnegie C; Martin KF; Boelaert K; Gilbert J; Higham CE; Muller I; Murray RD; Perros P; Razvi S; Vaidya B; Wernig F; Kahaly GJ
    Thyroid; 2019 Jul; 29(7):1003-1011. PubMed ID: 31194638
    [No Abstract]   [Full Text] [Related]  

  • 9. RELATIONSHIP BETWEEN THE EFFECTIVENESS OF INORGANIC IODINE AND THE SEVERITY OF GRAVES THYROTOXICOSIS: A RETROSPECTIVE STUDY.
    Honda A; Uchida T; Komiya K; Goto H; Takeno K; Sato J; Suzuki R; Himuro M; Watada H
    Endocr Pract; 2017 Dec; 23(12):1408-1413. PubMed ID: 29144795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
    Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation.
    Wang F; Zhang SJ; Yao X; Tian DM; Zhang KQ; She DM; Guo FF; Zhai QW; Ying H; Xue Y
    Endocrine; 2017 Jul; 57(1):125-137. PubMed ID: 28547036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' disease presenting as bi-ventricular heart failure with severe pulmonary hypertension and pre-eclampsia in pregnancy--a case report and review of the literature.
    Sabah KM; Chowdhury AW; Islam MS; Cader FA; Kawser S; Hosen MI; Saleh MA; Alam MS; Chowdhury MM; Tabassum H
    BMC Res Notes; 2014 Nov; 7():814. PubMed ID: 25927843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airflow obstruction and left ventricular filling pressure in suspected chronic obstructive pulmonary disease.
    Yu YH; Chen MZ; Wen LL; Chu CC; Chiang CT; Chen CH; Lin YJ
    Respir Physiol Neurobiol; 2014 Feb; 192():85-9. PubMed ID: 24361463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum level of IL-7 in patients with active Graves' disease.
    Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
    Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.
    Kasagi K; Takeuchi R; Misaki T; Kousaka T; Miyamoto S; Iida Y; Konishi J
    J Endocrinol Invest; 1997 Apr; 20(4):183-8. PubMed ID: 9211123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
    Popoveniuc G; Sharma M; Devdhar M; Wexler JA; Carroll NM; Wartofsky L; Burman KD
    Thyroid; 2010 Sep; 20(9):1015-8. PubMed ID: 20718680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mean arterial blood flow depends on the intensity of thyrotoxicosis in patients with Graves' disease].
    Czarkowski M; Hilgertner L; Powałowski T; Radomski D
    Pol Merkur Lekarski; 2005 Jun; 18(108):667-70. PubMed ID: 16124380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the resistance of large conduit arteries also decreased in thyrotoxic patients with Graves' disease?
    Czarkowski M; Hilgertner L; Powałowski T; Radomski D; Mikulska M
    Thyroid; 2005 Apr; 15(4):377-81. PubMed ID: 15876163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
    Tagami T; Hagiwara H; Kimura T; Usui T; Shimatsu A; Naruse M
    Thyroid; 2007 Aug; 17(8):767-72. PubMed ID: 17651013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.